Financial Snapshot

Revenue
$441.7M
TTM
Gross Margin
87.86%
TTM
Net Earnings
-$20.32M
TTM
Current Assets
Current Liabilities
Current Ratio
Total Assets
Total Liabilities
Book Value
Cash
P/E
-21.85
Nov 15, 2024 EST
Free Cash Flow
-$6.758M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $245.3M $205.6M $198.9M $212.2M $172.6M $138.0M $91.51M $16.21M $10.83M $21.19M $6.800M $10.60M $3.000M $1.700M $1.100M $700.0K $700.0K $100.0K $400.0K $700.0K $400.0K $2.900M $9.500M $18.50M $12.50M $8.100M $5.300M $2.600M
YoY Change 19.3% 3.39% -6.27% 22.94% 25.08% 50.78% 464.61% 49.68% -48.89% 211.56% -35.85% 253.33% 76.47% 54.55% 57.14% 0.0% 600.0% -75.0% -42.86% 75.0% -86.21% -69.47% -48.65% 48.0% 54.32% 52.83% 103.85%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Revenue $245.3M $205.6M $198.9M $212.2M $172.6M $138.0M $91.51M $16.21M $10.83M $21.19M $6.800M $10.60M $3.000M $1.700M $1.100M $700.0K $700.0K $100.0K $400.0K $700.0K $400.0K $2.900M $9.500M $18.50M $12.50M $8.100M $5.300M $2.600M
Cost Of Revenue $25.21M $17.56M $21.14M $23.54M $21.81M $22.65M $12.71M $4.782M $4.800M $2.853M $500.0K $1.100M $1.800M $4.800M $5.200M $5.000M $2.600M $1.700M $11.80M $10.80M $6.500M $3.600M
Gross Profit $220.1M $188.1M $177.7M $188.6M $150.8M $115.3M $78.80M $11.43M $6.028M $18.33M $6.300M $9.500M $1.200M -$4.600M -$4.800M -$4.300M -$2.200M $1.200M -$2.300M $7.700M $6.000M $4.500M
Gross Profit Margin 89.72% 91.46% 89.37% 88.91% 87.37% 83.59% 86.11% 70.5% 55.67% 86.53% 92.65% 89.62% 40.0% -4600.0% -1200.0% -614.29% -550.0% 41.38% -24.21% 41.62% 48.0% 55.56%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Selling, General & Admin $166.1M $131.8M $96.42M $75.69M $60.07M $47.75M $38.18M $7.839M $4.829M $3.324M $2.500M $3.500M $4.300M $3.300M $3.600M $3.100M $2.800M $2.800M $2.300M $1.700M $1.200M $2.200M $8.300M $6.300M $7.500M $5.800M $4.900M $3.400M
YoY Change 26.01% 36.71% 27.39% 26.01% 25.81% 25.04% 387.12% 62.33% 45.28% 32.96% -28.57% -18.6% 30.3% -8.33% 16.13% 10.71% 0.0% 21.74% 35.29% 41.67% -45.45% -73.49% 31.75% -16.0% 29.31% 18.37% 44.12%
% of Gross Profit 75.47% 70.09% 54.25% 40.12% 39.84% 41.4% 48.46% 68.61% 80.11% 18.13% 39.68% 36.84% 358.33% 183.33% 81.82% 125.0% 128.89%
Research & Development $66.81M $52.53M $70.37M $38.52M $28.97M $29.49M $19.05M $15.71M $14.18M $11.66M $10.20M $19.40M $13.80M $21.20M $24.50M $20.90M $19.10M $8.400M $8.900M $5.500M $5.700M $3.200M $10.50M $14.30M $11.10M $8.000M $6.800M $3.100M
YoY Change 27.18% -25.35% 82.69% 32.98% -1.78% 54.81% 21.24% 10.81% 21.58% 14.34% -47.42% 40.58% -34.91% -13.47% 17.22% 9.42% 127.38% -5.62% 61.82% -3.51% 78.13% -69.52% -26.57% 28.83% 38.75% 17.65% 119.35%
% of Gross Profit 30.35% 27.93% 39.59% 20.42% 19.21% 25.57% 24.17% 137.52% 235.24% 63.62% 161.9% 204.21% 1150.0% 266.67% 185.71% 185.0% 177.78%
Depreciation & Amortization $15.93M $13.19M $19.61M $8.314M $5.286M $6.697M $3.487M $771.9K $546.0K $1.400M $1.400M $1.200M $1.000M $800.0K $1.000M $1.000M $4.000M $3.000M $1.300M $1.000M $200.0K $600.0K
YoY Change 20.75% -32.75% 135.87% 57.28% -21.07% 92.06% 351.72% 41.38% 0.0% 16.67% 20.0% 25.0% -20.0% 0.0% -75.0% 33.33% 130.77% 30.0% 400.0% -66.67%
% of Gross Profit 7.24% 7.01% 11.03% 4.41% 3.51% 5.81% 4.43% 6.76% 9.06% 83.33% 38.96% 21.67% 22.22%
Operating Expenses $241.9M $169.8M $164.2M $112.4M $88.59M $76.54M $56.43M $23.21M $18.86M $14.88M $12.70M $22.60M $17.90M $25.10M $28.70M $25.90M $25.00M $13.00M $13.60M $9.000M $8.400M $6.300M $22.80M $23.50M $20.00M $14.70M $11.80M $7.200M
YoY Change 42.41% 3.45% 46.08% 26.85% 15.74% 35.64% 143.13% 23.05% 26.79% 17.14% -43.81% 26.26% -28.69% -12.54% 10.81% 3.6% 92.31% -4.41% 51.11% 7.14% 33.33% -72.37% -2.98% 17.5% 36.05% 24.58% 63.89%
Operating Profit -$21.75M $18.23M $13.56M $76.26M $62.19M $38.79M $22.37M -$11.78M -$12.83M $3.456M -$6.400M -$13.10M -$16.70M -$17.60M -$18.40M -$13.30M -$10.60M -$5.100M -$25.10M -$15.80M -$14.00M -$10.20M
YoY Change -219.29% 34.45% -82.22% 22.61% 60.32% 73.38% -289.88% -8.19% -471.35% -154.0% -51.15% -21.56% -4.35% 38.35% 25.47% 107.84% -79.68% 58.86% 12.86% 37.25%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Interest Expense -$6.625M -$3.246M $9.517M -$28.42M -$11.59M -$16.27M -$56.66M -$3.588M $2.877M -$8.644M -$8.100M -$4.400M $700.0K -$13.60M -$4.100M -$1.700M -$3.200M -$1.500M $600.0K $300.0K -$200.0K $500.0K -$9.700M -$6.800M $1.400M $1.200M $900.0K $400.0K
YoY Change 104.1% -134.11% -133.49% 145.29% -28.8% -71.28% 1479.0% -224.72% -133.28% 6.72% 84.09% -728.57% -105.15% 231.71% 141.18% -46.88% 113.33% -350.0% 100.0% -250.0% -140.0% -105.15% 42.65% -585.71% 16.67% 33.33% 125.0%
% of Operating Profit -17.8% 70.18% -37.27% -18.63% -41.94% -253.22% -250.12%
Other Income/Expense, Net $0.00 -$3.744M -$2.943M -$21.65M -$53.21M -$2.534M $0.00 $0.00 -$2.300M $0.00 -$2.900M $200.0K $4.900M -$8.100M $1.000M $0.00
YoY Change -100.0% 27.23% -86.41% -59.32% 1999.72% -100.0% -100.0% -1550.0% -95.92% -160.49% -910.0%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Pretax Income -$12.01M $14.99M $23.08M $44.09M $47.66M $875.1K -$87.50M -$17.91M -$9.957M -$5.767M -$15.10M -$24.10M -$17.80M -$60.60M -$31.70M -$26.20M -$35.90M -$18.50M -$17.90M -$13.00M -$11.00M -$900.0K -$54.10M -$22.60M -$12.60M -$17.40M -$5.600M -$4.200M
YoY Change -180.15% -35.06% -47.66% -7.49% 5346.79% -101.0% 388.65% 79.83% 72.65% -61.81% -37.34% 35.39% -70.63% 91.17% 20.99% -27.02% 94.05% 3.35% 37.69% 18.18% 1122.22% -98.34% 139.38% 79.37% -27.59% 210.71% 33.33%
Income Tax -$1.464M $1.313M $7.082M $6.348M $10.71M -$24.65M -$9.641M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 -$4.300M $300.0K $0.00 -$300.0K -$100.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 8.76% 30.69% 14.4% 22.46% -2816.34%
Net Earnings -$10.55M $13.67M $16.00M $37.75M $36.96M $25.52M -$77.86M -$17.91M -$9.957M -$5.767M -$15.10M -$24.10M -$17.10M -$50.20M -$32.10M -$26.20M -$35.60M -$18.50M -$17.90M -$13.00M -$11.00M -$900.0K -$54.10M -$22.60M -$12.60M -$17.40M -$5.600M -$4.200M
YoY Change -177.14% -14.52% -57.62% 2.13% 44.82% -132.78% 334.8% 79.83% 72.65% -61.81% -37.34% 40.94% -65.94% 56.39% 22.52% -26.4% 92.43% 3.35% 37.69% 18.18% 1122.22% -98.34% 139.38% 79.37% -27.59% 210.71% 33.33%
Net Earnings / Revenue -4.3% 6.65% 8.04% 17.79% 21.41% 18.5% -85.08% -110.48% -91.96% -27.22% -222.06% -227.36% -570.0% -2952.94% -2918.18% -3742.86% -5085.71% -18500.0% -4475.0% -1857.14% -2750.0% -31.03% -569.47% -122.16% -100.8% -214.81% -105.66% -161.54%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.02 $0.02 $22.81K $55.29K $54.87K $39.05K -$155.6K -$43.11K -$24.18K -$14.56K -$70.36K -$327.9K -$360.8K -$1.873M -$2.744M -$2.848M -$3.870M -$2.126M -$2.238M -$2.203M -$3.333M -$473.7K -$38.64M -$16.14M -$9.692M -$13.38M -$4.308M -$3.231M

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Cash & Short-Term Investments $213.4M $207.3M $191.9M $205.2M $74.35M $82.01M $59.89M $32.56M $31.64M $34.19M $17.00M $5.300M $3.800M $10.30M $15.90M $23.40M $54.90M $31.10M $20.30M $25.80M $2.700M $500.0K $1.200M $44.90M $52.70M $71.30M $12.80M $8.200M
YoY Change 2.93% 8.03% -6.45% 175.94% -9.34% 36.92% 83.94% 2.9% -7.44% 101.09% 220.75% 39.47% -63.11% -35.22% -32.05% -57.38% 76.53% 53.2% -21.32% 855.56% 440.0% -58.33% -97.33% -14.8% -26.09% 457.03% 56.1%
Cash & Equivalents $61.52M $207.3M $191.9M $205.2M $74.35M $82.01M $59.89M $32.56M $31.64M $34.19M $17.00M $5.300M $3.800M $10.30M $15.90M $19.60M $51.00M $26.10M $14.50M $21.70M $2.700M $500.0K $1.200M $44.90M $52.70M $71.30M $12.80M $8.200M
Short-Term Investments $151.7M $0.00 $3.700M $4.000M $5.000M $5.800M $4.100M
Other Short-Term Assets $3.543M $213.0K $2.619M $5.012M $0.00 $1.851M $1.100M $994.5K $227.0K $144.0K $2.200M $700.0K $2.000M $100.0K $900.0K $1.100M $10.90M $700.0K $800.0K $600.0K $500.0K $4.200M $9.000M $5.500M $6.400M $4.100M $1.000M $1.500M
YoY Change 1563.38% -91.87% -47.75% -100.0% 68.34% 10.57% 338.13% 57.64% -93.45% 214.29% -65.0% 1900.0% -88.89% -18.18% -89.91% 1457.14% -12.5% 33.33% 20.0% -88.1% -53.33% 63.64% -14.06% 56.1% 310.0% -33.33%
Inventory $56.76M $42.33M $27.31M $21.16M $16.22M $17.68M $18.72M $18.32M $16.23M $13.40M $4.800M $2.100M $6.600M $9.000M $11.30M $11.00M $11.70M $9.200M $3.900M $2.500M $3.100M $2.900M $0.00 $300.0K $0.00 $100.0K $200.0K $200.0K
Prepaid Expenses
Receivables $35.41M $27.62M $18.08M $23.51M $28.86M $15.66M $9.083M $6.412M $2.106M $701.0K $200.0K $400.0K $9.000M $0.00 $600.0K $0.00 $3.300M $2.200M $2.200M $1.500M $800.0K
Other Receivables $7.207M $0.00 $9.515M $8.370M $0.00 $680.0K $1.315M $5.214M $887.0K $709.0K $400.0K $400.0K $800.0K $200.0K $0.00 $0.00 $400.0K $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $316.3M $277.5M $249.4M $263.2M $119.4M $117.9M $90.11M $63.50M $51.09M $49.14M $24.60M $8.400M $13.20M $29.20M $28.60M $36.00M $78.70M $42.40M $25.50M $29.10M $6.300M $8.200M $10.20M $54.30M $61.30M $77.70M $15.50M $10.70M
YoY Change 14.0% 11.25% -5.23% 120.38% 1.32% 30.81% 41.91% 24.29% 3.97% 99.77% 192.86% -36.36% -54.79% 2.1% -20.56% -54.26% 85.61% 66.27% -12.37% 361.9% -23.17% -19.61% -81.22% -11.42% -21.11% 401.29% 44.86%
Property, Plant & Equipment $33.47M $39.15M $33.17M $21.65M $16.30M $8.579M $8.408M $6.170M $5.661M $5.598M $6.200M $7.100M $11.10M $8.300M $7.000M $5.900M $8.200M $8.200M $5.500M $5.100M $4.400M $5.800M $7.600M $26.80M $19.00M $8.700M $4.000M $1.800M
YoY Change -14.51% 18.03% 53.17% 32.88% 89.94% 2.04% 36.26% 9.0% 1.13% -9.71% -12.68% -36.04% 33.73% 18.57% 18.64% -28.05% 0.0% 49.09% 7.84% 15.91% -24.14% -23.68% -71.64% 41.05% 118.39% 117.5% 122.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.40M $9.731M $8.650M $7.118M $6.177M $0.00 $0.00 $200.0K $200.0K $200.0K $100.0K $500.0K $600.0K $300.0K $4.100M $0.00 $100.0K $100.0K $200.0K
YoY Change 6.85% 12.5% 21.52% 15.23% -100.0% 0.0% 0.0% 100.0% -80.0% -16.67% 100.0% -92.68% -100.0% 0.0% -50.0%
Other Assets $31.38M $24.30M $22.22M $32.39M $34.61M $39.01M $13.35M $1.909M $200.0K $200.0K $200.0K $700.0K -$2.400M -$20.00M -$3.400M -$1.400M -$900.0K -$700.0K -$500.0K -$900.0K
YoY Change 29.14% 9.35% -31.39% -6.41% -11.29% 192.22% 599.14% 854.72% 0.0% 0.0% -71.43% -129.17% -88.0% 488.24% 142.86% 55.56% 28.57% 40.0% -44.44%
Total Long-Term Assets $146.5M $148.3M $147.9M $155.2M $136.5M $101.1M $79.58M $65.96M $6.585M $6.575M $6.800M $8.400M $11.50M $8.100M $27.30M $31.10M $35.60M $36.70M $9.100M $8.700M $6.400M $8.300M $13.90M $44.60M $21.70M $11.50M $6.400M $3.600M
YoY Change -1.2% 0.29% -4.75% 13.75% 34.95% 27.08% 20.66% 901.6% 0.15% -3.31% -19.05% -26.96% 41.98% -70.33% -12.22% -12.64% -3.0% 303.3% 4.6% 35.94% -22.89% -40.29% -68.83% 105.53% 88.7% 79.69% 77.78%
Total Assets $462.9M $425.8M $397.3M $418.5M $255.9M $219.0M $169.7M $129.5M $57.68M $55.72M $31.40M $16.80M $24.70M $37.30M $55.90M $67.10M $114.3M $79.10M $34.60M $37.80M $12.70M $16.50M $24.10M $98.90M $83.00M $89.20M $21.90M $14.30M
YoY Change
Accounts Payable $16.02M $54.47M $40.93M $46.87M $40.65M $6.782M $9.629M $5.771M $1.016M $2.943M $4.000M $1.100M $2.000M $2.900M $5.100M $2.500M $2.800M $3.300M $3.700M $600.0K $400.0K $1.000M $8.100M $5.000M $5.600M $2.700M $2.500M $600.0K
YoY Change -70.58% 33.06% -12.67% 15.32% 499.31% -29.57% 66.84% 468.03% -65.48% -26.43% 263.64% -45.0% -31.03% -43.14% 104.0% -10.71% -15.15% -10.81% 516.67% 50.0% -60.0% -87.65% 62.0% -10.71% 107.41% 8.0% 316.67%
Accrued Expenses $56.51M $45.71M $1.505M $616.0K $2.187M $0.00 $222.6K $187.0K $600.0K $2.500M $2.300M $500.0K $1.500M $500.0K $400.0K
YoY Change 23.61% 2937.34% 144.32% -100.0% 19.04% -76.0% 8.7% 360.0% -66.67% 200.0% 25.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $23.20M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $1.400M $1.900M $2.700M $0.00 $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -26.32% -29.63%
Long-Term Debt Due $5.440M $5.233M $4.298M $4.002M $53.31M $36.25M $23.14M $26.96M $3.310M $626.0K $800.0K $900.0K $1.200M $100.0K $100.0K $100.0K $10.30M $1.600M $0.00 $0.00 $5.600M $2.000M $5.500M $11.60M $4.000M $400.0K $500.0K $500.0K
YoY Change 3.96% 21.75% 7.4% -92.49% 47.07% 56.65% -14.16% 714.38% 428.75% -21.75% -11.11% -25.0% 1100.0% 0.0% 0.0% -99.03% 543.75% -100.0% 180.0% -63.64% -52.59% 190.0% 900.0% -20.0% 0.0%
Total Short-Term Liabilities $77.97M $59.70M $46.77M $76.85M $114.3M $84.34M $62.02M $52.46M $13.48M $14.87M $12.90M $9.000M $8.100M $9.700M $36.30M $12.60M $23.50M $9.200M $5.700M $1.500M $6.700M $5.000M $18.10M $21.50M $10.90M $5.000M $3.800M $1.600M
YoY Change 30.6% 27.64% -39.14% -32.74% 35.47% 35.98% 18.23% 289.33% -9.4% 15.29% 43.33% 11.11% -16.49% -73.28% 188.1% -46.38% 155.43% 61.4% 280.0% -77.61% 34.0% -72.38% -15.81% 97.25% 118.0% 31.58% 137.5%
Long-Term Debt $166.1M $161.5M $157.5M $158.0M $4.893M $38.22M $60.81M $41.86M $12.56M $965.0K $1.200M $2.000M $2.200M $200.0K $2.000M $38.10M $52.50M $6.000M $100.0K $200.0K $200.0K $300.0K $6.800M $25.10M $2.300M $1.600M $2.200M $2.500M
YoY Change 2.88% 2.54% -0.31% 3128.22% -87.2% -37.14% 45.27% 233.4% 1201.04% -19.58% -40.0% -9.09% 1000.0% -90.0% -94.75% -27.43% 775.0% 5900.0% -50.0% 0.0% -33.33% -95.59% -72.91% 991.3% 43.75% -27.27% -12.0%
Other Long-Term Liabilities $0.00 $165.0K $212.0K $19.38M $33.39M $30.41M $7.090M $7.808M $10.04M $12.30M $13.60M $15.50M $17.30M $0.00 $10.10M $0.00
YoY Change -100.0% -22.17% -98.91% -41.96% 9.79% 328.95% -9.19% -22.21% -18.4% -9.56% -12.26% -10.4% -100.0%
Total Long-Term Liabilities $166.1M $161.5M $157.6M $158.2M $24.27M $71.61M $91.22M $48.95M $20.36M $11.00M $13.50M $15.60M $17.70M $17.50M $2.000M $38.10M $52.50M $16.10M $100.0K $200.0K $200.0K $300.0K $6.800M $25.10M $2.300M $1.600M $2.200M $2.500M
YoY Change 2.88% 2.43% -0.34% 551.63% -66.1% -21.5% 86.36% 140.38% 85.08% -18.5% -13.46% -11.86% 1.14% 775.0% -94.75% -27.43% 226.09% 16000.0% -50.0% 0.0% -33.33% -95.59% -72.91% 991.3% 43.75% -27.27% -12.0%
Total Liabilities $244.1M $221.2M $204.4M $235.0M $138.5M $156.0M $153.2M $101.4M $33.84M $25.88M $26.40M $24.50M $25.90M $26.40M $42.60M $54.60M $79.70M $29.20M $5.800M $1.800M $7.000M $5.300M $24.90M $46.60M $13.20M $6.600M $6.000M $4.000M
YoY Change 10.36% 8.2% -13.03% 69.66% -11.17% 1.77% 51.11% 199.7% 30.77% -1.99% 7.76% -5.41% -1.89% -38.03% -21.98% -31.49% 172.95% 403.45% 222.22% -74.29% 32.08% -78.71% -46.57% 253.03% 100.0% 10.0% 50.0%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $443.98 Million

About

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The company is headquartered in Leiden, Zuid-Holland and currently employs 415 full-time employees. The firm is engaged in the development, production and commercialization of human therapeutic proteins to be used in the therapies. The firm's product portfolio is aimed at treatments for genetic disorders, blood-related disorders, infectious and inflammatory diseases, tissue and bone damage and surgical/traumatic bleeding. Its core product, RUCONEST (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute Hereditary Angioedema (HAE) attacks in patients in Europe, the Unites States, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

Industry: Pharmaceutical Preparations Peers: LAVA Therapeutics NV Merus NV ProQR Therapeutics NV Uniqure NV